Ryman Healthcare (RYM.AX) Earnings Analysis
Ryman Healthcare (RYM.AX) has no confirmed upcoming earnings date. Trailing P/E -13.92.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RYM.AX next report earnings?
No confirmed upcoming earnings date is currently scheduled for RYM.AX. This page updates as the calendar is published.
RYM.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-26 | -0.12 AUD | n/a | n/a | n/a |
| 2025-05-29 | -0.75 AUD | n/a | n/a | n/a |
RYM.AX valuation and analyst view
| Trailing P/E | -13.92 |
|---|---|
| Trailing EPS | -0.16884 AUD |
| Price / book | 0.57 |
| Dividend yield | 0.00% |
| Market cap | 1.85B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Ryman Healthcare (RYM.AX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for RYM.AX. This page updates as the calendar is published.
Did RYM.AX beat earnings last quarter?
Consensus estimate data was not available for RYM.AX's 2026-05-26 report.
What is RYM.AX's current P/E ratio and EPS?
RYM.AX trades at a trailing P/E of -13.92 on trailing EPS of -0.16883687803227773 AUD.
What do analysts rate RYM.AX?
RYM.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.